The number of people with susceptibility test result for rifampicin in Guam
Guam: The number of people with susceptibility test result for rifampicin was 92.11 in 2021. ▼ Falling
Latest (2021)
92.11
Change on year
down 5.5%
World rank
62nd
of 146 countries
All-time high
100
in 2018
All-time low
92.11
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Guam, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Guam recorded 92.11 for the number of people with susceptibility test result for rifampicin in 2021. That is the lowest value across all 5 years on record.
Compared with earlier readings it is down 5.5% on the previous year and down 6.2% over five years.
That places Guam 62nd out of 146 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Guam, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 98.25 | — |
| 2018 | 100 | +1.8% |
| 2019 | 98.08 | -1.9% |
| 2020 | 97.44 | -0.7% |
| 2021 | 92.11 | -5.5% |
Guam compared with similar countries
- Guam's 92.11 is below the median for high income countries, which is 92.6, 99% of the median. (56 countries reporting)
- Guam's 92.11 is below the median for East Asia & Pacific, which is 96.47, 95% of the median. (28 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 98.77 | 98.08 | 100 | 3 |
| 2020s | 94.77 | 92.11 | 97.44 | 2 |
Countries ranked near Guam
More health data for Guam
- Heat deaths vs projected death rates, annual growth rate 0.5954 % change on previous year (2090)
- Number of infants who die before age 1 5 deaths (2100)
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Estimated changes in temperature-related death rates compared to projected death rates 946.2 deaths per 1,000 people (2090)
- Population ages 75-79, male, per unit of GDP 0 units per US$ of GDP (2022)
- Age population, age 06, male, interpolated 1,539 (2025)
- Population ages 75-79, male, per capita 0.0117 units per person (2025)
- Population ages 80 and above, female, per capita 0.0146 units per person (2025)
- Population ages 80 and above, male, per unit of GDP 0 units per US$ of GDP (2022)
- Population ages 80 and above, male, annual growth rate 7.99 % change on previous year (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Guam?
- The number of people with susceptibility test result for rifampicin in Guam was 92.11 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Guam?
- The highest recorded value was 100 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Guam?
- The lowest recorded value was 92.11 in 2021.
- How does Guam rank for the number of people with susceptibility test result for rifampicin?
- Guam ranks 62nd out of 146 countries with data for 2021.
- Where does this Guam data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).